Patients who have received doses higher than recommended should be carefully monitored. Overdosage may cause clinically significant hypocalcemia, hypophosphatemia, and hypomagnesemia. Clinically relevant reductions in serum levels of calcium, phosphorus, and magnesium should be corrected by IV administration of calcium gluconate, potassium or sodium phosphate, and magnesium sulfate, respectively.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
